Effects of vitamin A and D receptor gene polymorphisms/haplotypes on immune responses to measles vaccine

Pharmacogenetics and Genomics

Volumn 22, Issue 1, 2012, Pages 20-31

  Ovsyannikova, Inna G ^a   Haralambieva, Iana H ^a   Vierkant, Robert A ^a   O'Byrne, Megan M ^a   Jacobson, Robert M ^a   Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

genes; immunogenetics; measles vaccine immunity; single nucleotide polymorphisms; vitamin A receptor; vitamin D receptor

Indexed keywords

ALPHA INTERFERON; DNA; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 29; INTERLEUKIN 6; MEASLES ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; NEUTRALIZING ANTIBODY; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; RETINOID X RECEPTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR;

3' UNTRANSLATED REGION; ADOLESCENT; ADULT; AFRICAN AMERICAN; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSPOT ASSAY; EUROPEAN AMERICAN; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INTRON; MALE; MEASLES; MUMPS; NORMAL HUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; RUBELLA; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; VACCINATION; VIRUS IMMUNITY;

EID: 83655201206     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e32834df186     Document Type: Article

References (39)

1. Mora JR, Iwata M, Von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008; 8:685-698.
2. De la Torre MS, Torres C, Nieto G, Vergara S, Carrero AJ, Macias J, et al. Vitamin D receptor gene haplotypes and susceptibility to HIV-1 infection in injection drug users. J Infect Dis 2008; 197:405-410. (Pubitemid 351263422)
3. Motsinger-Reif AA, Antas PR, Oki NO, Levy S, Holland SM, Sterling TR. Polymorphisms in IL-1beta, vitamin D receptor Fok1, and Toll-like receptor 2 are associated with extrapulmonary tuberculosis. BMC Med Genet 2010; 11:37.
4. Bellamy R, Ruwende C, Corrah T, McAdam KP, Thursz M,Whittle HC, et al. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis 1999; 179:721-724. (Pubitemid 30016163)
5. Saito M, Eiraku N, Usuku K, Nobuhara Y, Matsumoto W, Kodama D, et al. ApaI polymorphism of vitamin D receptor gene is associated with susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in HTLV-1 infected individuals. J Neurol Sci 2005; 232:29-35. (Pubitemid 40585839)
6. Ovsyannikova IG, Haralambieva IH, Dhiman N, O'Byrne MM, Pankratz VS, Jacobson RM, et al. Polymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccination. J Infect Dis 2010; 201:207-213.
7. Ovsyannikova IG, Dhiman N, Haralambieva IH, Vierkant RA, O'Byrne MM, Jacobson RM, et al. Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes. Hum Genet 2010; 127:207-221.
8. Ovsyannikova IG, Pankratz SV, Vierkant R, Jacobson RM, Poland GA. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine. J Infect Dis 2006; 193:655-663. (Pubitemid 43273493)
9. Dhiman N, Ovsyannikova IG, Cunningham JM, Vierkant RA, Kennedy RB, Pankratz VS, et al. Associations between measles vaccine immunity and single nucleotide polymorphisms in cytokine and cytokine receptor genes. J Infect Dis 2007; 195:21-29. (Pubitemid 44958223)
10. Ovsyannikova IG, Haralambieva IH, Vierkant RA, Pankratz VS, Poland GA. The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity. Hum Genet 2011; 130:547-561.
11. Dhiman N, Cunningham JM, Jacobson RM, Vierkant RA,Wu Y, Ovsyannikova IG, et al. Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors. J Allergy Clin Immunol 2007; 120:666-672. (Pubitemid 47320741)
12. Haralambieva IH, Dhiman N, Ovsyannikova IG, Vierkant RA, Pankratz VS, Jacobson RM, et al. Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine. Hum Immunol 2010; 71:383-391.
13. Haralambieva IH, Ovsyannikova IG, Vierkant RA, Poland GA. Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles immunity. Clin Vaccine Immunol 2008; 15:1054-1059. (Pubitemid 352018321)
14. Ryan JE, Ovsyannikova IG, Poland GA. Detection of measles virus-specific IFN-gamma-secreting T-cells by ELISPOT. In: Kalyuzhyny AE, editor. Handbook of ELISPOT: Methods and Protocols. Totowa, NJ: Humana Press Inc. 2005; pp. 207-217.
15. Ovsyannikova IG, Dhiman N, Jacobson RM, Vierkant RA, Pankratz VS, Poland GA. HLA homozygosity does not adversely effect measles vaccineinduced cytokine responses. Virology 2007; 364:87-94. (Pubitemid 46829285)
16. Ryan JE, Dhiman N, Ovsyannikova IG, Vierkant RA, Pankratz VS, Poland GA. Response surface methodology to determine optimal cytokine responses in human peripheral blood mononuclear cells after smallpox vaccination. J Immunol Methods 2009; 341:97-105.
17. Dhiman N, Haralambieva IH, Vierkant RA, Pankratz VS, Ryan JE, Jacobson RM, et al. Predominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in health vaccines. Cytokine 2010; 50:24-29.
18. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004; 74:106-120. (Pubitemid 38085242)
19. Ovsyannikova IG, Haralambieva IH, Vierkant RA, O'Byrne MM, Jacobson RM, Poland GA. The Association of CD46, SLAM, and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms. Hum Hered 2011 (in press).
20. Haralambieva IH, Ovsyannikova IG, Kennedy RB, Vierkant RA, Pankratz VS, Jacobson RM, et al. Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination. Vaccine 2011; 29:7883-7895.
21. Weir BS. Genetic data Analysis II: methods for discrete population genetic data. Sunderland, Massachusetts: Sinauer Associates, Inc. 1996; pp. 98-99.
22. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21:263-265. (Pubitemid 40202029)
23. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70:425-434. (Pubitemid 34112296)
24. Storey JD. A direct approach to false discovery rates. J R Statist Soc B 2002; 64:479-498.
25. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003; 100:9440-9445. (Pubitemid 37033947)
26. Suneetha PV, Sarin SK, Goyal A, Kumar GT, Shukla DK, Hissar S. Association between vitamin D receptor, CCR5, TNF-alpha and TNF-beta gene polymorphisms and HBV infection and severity of liver disease. J Hepatol 2006; 44:856-863.
27. Benn CS, Aaby P, Bale C, Olsen J, Michaelsen KF, George E, et al. Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, West Africa. Lancet 1997; 350:101-105. (Pubitemid 27313635)
28. Bahl R, Bhandari N, Kant S, Molbak K, Ostergaard E, Bhan MK. Effect of vitamin A administered at Expanded Program on Immunization contacts on antibody response to oral polio vaccine. Eur J Clin Nutr 2002; 56:321-325. (Pubitemid 34413825)
29. Diness BR, Martins CL, Bale C, Garly ML, Ravn H, Rodrigues A, et al. The effect of high-dose vitamin A supplementation at birth on measles incidence during the first 12 months of life in boys and girls: an unplanned study within a randomised trial. Br J Nutr 2011; 1-4.
30. Hope-Simpson RE. The role of season in the epidemiology of influenza. J Hyg (London) 1981; 86:35-47. (Pubitemid 11167452)
31. Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, et al. Epidemic influenza and vitamin D. Epidemiol Infect 2006; 134:1129-1140. (Pubitemid 44614932)
32. Cantorna MT, Mahon BD. D-hormone and the immune system. J Rheumatol Suppl 2005; 76:11-20. (Pubitemid 41324839)
33. Abu-Amer Y, Bar-Shavit Z. Regulation of TNF-alpha release from bone marrow-derived macrophages by vitamin D. J Cell Biochem 1994; 55:435-444. (Pubitemid 24268148)
34. Staeva-Vieira TP, Freedman LP. 1,25-dihydroxyvitamin D3 inhibits IFNgamma and IL-4 levels during in vitro polarization of primary murine CD4 + T cells. J Immunol 2002; 168:1181-1189. (Pubitemid 34094483)
35. Penna G, Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000; 164:2405-2411. (Pubitemid 30115468)
36. Farquharson C, Law AS, Seawright E, Burt DW, Whitehead CC. The expression of transforming growth factor-beta by cultured chick growth plate chondrocytes: differential regulation by 1,25-dihydroxyvitamin D3. J Endocrinol 1996; 149:277-285. (Pubitemid 26173538)
37. Bellamy RJ, Hill AVS. Host genetic susceptibility to human tuberculosis. In: Chadwick DJ, Cardew G, editors. Genetics and tuberculosis. Chichester, UK: Wiley. 1998; pp. 3-23. (Pubitemid 128685123)
38. Yuan HY, Chiou JJ, Tseng WH, Liu CH, Liu CK, Lin YJ, et al. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 2006; 34:635-641.
39. Black DL. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 2003; 72:291-336. (Pubitemid 36930448)